NR4A1 and neoplasm: Other clinical and histopathological characteristics such as volume, tumor location, lymph-vascular invasion, and diffusion-weighted imaging radiomics may also be good signatures for distinguishing positive and negative status of hormone receptors in breast cancer (25, 34).